phyrago

Generic: dasatinib

Labeler: cycle pharmaceuticals ltd
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name phyrago
Generic Name dasatinib
Labeler cycle pharmaceuticals ltd
Dosage Form TABLET
Routes
ORAL
Active Ingredients

dasatinib 70 mg/1

Manufacturer
Cycle Pharmaceuticals Ltd

Identifiers & Regulatory

Product NDC 70709-153
Product ID 70709-153_f9591487-f923-47a9-b621-8871a87eee01
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA216099
Listing Expiration 2026-12-31
Marketing Start 2025-09-22

Pharmacologic Class

Classes
cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc] protein kinase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70709153
Hyphenated Format 70709-153

Supplemental Identifiers

RxCUI
643105 643107 643109 799047 1045402 1045406 2691837 2691839 2691841 2691843 2691845 2691847
UNII
RBZ1571X5H

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name phyrago (source: ndc)
Generic Name dasatinib (source: ndc)
Application Number NDA216099 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 70 mg/1
source: ndc
Packaging
  • 60 TABLET in 1 BOTTLE (70709-153-70)
source: ndc

Packages (1)

70709-153-70 60 TABLET in 1 BOTTLE (70709-153-70)

Ingredients (1)

dasatinib (70 mg/1)

Linked Drug Pages (1)

PHYRAGO ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "f9591487-f923-47a9-b621-8871a87eee01", "openfda": {"unii": ["RBZ1571X5H"], "rxcui": ["643105", "643107", "643109", "799047", "1045402", "1045406", "2691837", "2691839", "2691841", "2691843", "2691845", "2691847"], "spl_set_id": ["60976d1e-c415-417f-8168-4e07999a7281"], "manufacturer_name": ["Cycle Pharmaceuticals Ltd"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (70709-153-70)", "package_ndc": "70709-153-70", "marketing_start_date": "20250922"}], "brand_name": "PHYRAGO", "product_id": "70709-153_f9591487-f923-47a9-b621-8871a87eee01", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]", "Protein Kinase Inhibitors [MoA]"], "product_ndc": "70709-153", "generic_name": "dasatinib", "labeler_name": "Cycle Pharmaceuticals Ltd", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHYRAGO", "active_ingredients": [{"name": "DASATINIB", "strength": "70 mg/1"}], "application_number": "NDA216099", "marketing_category": "NDA", "marketing_start_date": "20250922", "listing_expiration_date": "20261231"}